Through conferences and workshops for clinicians, the Gunderson Personality Disorders Institute aims to increase quality of care and access to treatment for patients with borderline personality disorder (BPD).
Course topics include dialectical behavior therapy (DBT), general psychiatric management (GPM), mentalization-based treatment (MBT)—offered in conjunction with the Anna Freud Centre for Children and Families, and transference-focused psychotherapy (TFP)—offered in conjunction with TFP-New York.
This 2-day workshop expands previous knowledge and embeds the basic skills of mentalization-based treatment (MBT) and is suitable for mental health and other professionals interested in enhancing what they have already learned and applied following the Basic MBT Training.
This 8-hour, self-paced continuing education course for health care professionals offers training in an empirically validated treatment approach to borderline personality disorder (BPD) known as general psychiatric management (GPM). The course utilizes group discussion, video clips, and clinical vignettes to promote interactive learning and a comprehensive understanding of the treatment.
Clinicians seeking advanced proficiency in treatment modalities are encouraged to register for upcoming clinician supervision offerings. Virtual sessions are run by Dr. Lois Choi-Kain and other certified trainers.
Supervision offerings include general psychiatric management (GPM), mentalization-based treatment (MBT), transference-focused psychotherapy (TFP), and more.
McLean Hospital provides professional education opportunities for a wide range of mental health and allied health professionals, including psychiatrists, psychologists, nurses, social workers, nationally certified counselors, nursing home administrators, and educators. Our fully accredited programming attracts a broad base of health providers for further training in a variety of specialties.
The Gunderson Personality Disorders Institute at McLean Hospital was founded in 2013 to elevate awareness and training for evidence-based treatments for BPD and accompanying psychiatric conditions.